Authors:
Okada, H
Attanucci, J
Giezeman-Smits, KM
Brissette-Storkus, C
Fellows, WK
Gambotto, A
Pollack, IF
Pogue-Geile, K
Lotze, MT
Bozik, ME
Chambers, WH
Citation: H. Okada et al., Immunization with an antigen identified by cytokine tumor vaccine-assistedSEREX (CAS) suppressed growth of the rat 9L glioma in vivo, CANCER RES, 61(6), 2001, pp. 2625-2631
Authors:
Jonges, LE
Giezeman-Smits, KM
van Vlierberghe, RLP
Ensink, NG
Hagenaars, M
Joly, E
Eggermont, AMM
van de Velde, CJH
Fleuren, GJ
Kuppen, PJK
Citation: Le. Jonges et al., NK cells modulate MHC class I expression on tumor cells and their susceptibility to lysis, IMMUNOBIOL, 202(4), 2000, pp. 326-338
Authors:
Giezeman-Smits, KM
Okada, H
Brissette-Storkus, CS
Villa, LA
Attanucci, J
Lotze, MT
Pollack, IF
Bozik, ME
Chambers, WH
Citation: Km. Giezeman-smits et al., Cytokine gene therapy of gliomas: Induction of reactive CD4(+) T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity, CANCER RES, 60(9), 2000, pp. 2449-2457
Authors:
Okada, H
Giezeman-Smits, KM
Tahara, H
Attanucci, J
Fellows, WK
Lotze, MT
Chambers, WH
Bozik, ME
Citation: H. Okada et al., Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine, GENE THER, 6(2), 1999, pp. 219-226